A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism

References

• Ahmed M, Cheng M, Cheung IY, Cheung NK. 2015. Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody. Oncoimmunology. 4(4):e989776.
   PubMed Web of Science ®Google Scholar
• Armendariz AD, Krauss RM. 2009. Hepatic nuclear factor 1- alpha: inflammation, genetics, and atherosclerosis. Curr Opin Lipidol. 20(2):106–111.
   PubMed Web of Science ®Google Scholar
• Aueviriyavit S, Furihata T, Morimoto K, Kobayashi K, Chiba K. 2007. Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers. Drug Metab Pharmacokinet. 22(5):391–398.
   PubMed Web of Science ®Google Scholar
• Babeu JP, Boudreau F. 2014. Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks. World J Gastroenterol. 20(1):22–30.
   PubMed Web of Science ®Google Scholar
• Barbier O, Girard H, Inoue Y, Duez H, Villeneuve L, Kamiya A, Fruchart JC, Guillemette C, Gonzalez FJ, Staels B. 2005. Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4α. Mol Pharmacol. 67(1):241–249.
   PubMed Web of Science ®Google Scholar
• Begum S. 2020. Hepatic nuclear factor 1 alpha (HNF-1α) in human physiology and molecular medicine. Curr Mol Pharmacol. 13(1):50–56.
   PubMed Web of Science ®Google Scholar
• Bélanger AS, Tojcic J, Harvey M, Guillemette C. 2010. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. BMC Mol Biol. 11:9.
   PubMed Web of Science ®Google Scholar
• Beysel S, Pinarli FA, Eyerci N, Kizilgul M, Hepsen S, Alhan A, Kan S, Caliskan M, Bozkurt E, Cakal E. 2020. HNF1A gene p.I27L is associated with co-existing preeclampsia in gestational diabetes mellitus. Gynecol Endocrinol. 36(6):530–534.
   PubMed Web of Science ®Google Scholar
• Bi Y, Wang Y, Xie W. 2019. The interplay between hepatocyte nuclear factor 4α (HNF4α) and cholesterol sulfotransferase (SULT2B1b) in hepatic energy homeostasis. Liver Res. 3(3–4):143–149.
   Google Scholar
• Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. 2007. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol. 13(19):2649–2654.
   PubMed Web of Science ®Google Scholar
• Bisceglia F, Battistelli C, Noce V, Montaldo C, Zammataro A, Strippoli R, Tripodi M, Amicone L, Marchetti A. 2019. TGFbeta impairs HNF1alpha functional activity in epithelial-to-mesenchymal transition interfering with the recruitment of CBP/p300 acetyltransferases. Front Pharmacol. 10:942.
   PubMed Web of Science ®Google Scholar
• Boj SF, Servitja JM, Martin D, Rios M, Talianidis I, Guigo R, Ferrer J. 2009. Functional targets of the monogenic diabetes transcription factors HNF-1alpha and HNF-4alpha are highly conserved between mice and humans. Diabetes. 58(5):1245–1253.
   PubMed Web of Science ®Google Scholar
• Bonzo JA, Patterson AD, Krausz KW, Gonzalez FJ. 2010. Metabolomics identifies novel Hnf1α-Dependent physiological pathways in vivo. Mol Endocrinol. 24(12):2343–2355.
   PubMedGoogle Scholar
• Chamouton J, Latruffe N. 2012. PPARα/HNF4α interplay on diversified responsive elements. Relevance in the regulation of liver peroxisomal fatty acid catabolism. Curr Drug Metab. 13(10):1436–1453.
   PubMed Web of Science ®Google Scholar
• Chang HR, Nam S, Kook MC, Kim KT, Liu X, Yao H, Jung HR, Lemos RJ, Seo HH, Park HS, et al. 2016. HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut. 65(1):19–32.
   PubMed Web of Science ®Google Scholar
• Chen L, Bao Y, Jiang S, Zhong XB. 2020. The roles of long noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in drug metabolism and human diseases. ncRNA. 6(2):24.
   Google Scholar
• Chen L, Bao Y, Piekos SC, Zhu K, Zhang L, Zhong XB. 2018. A transcriptional regulatory network containing nuclear receptors and long noncoding RNAs controls basal and drug-induced expression of cytochrome p450s in HepaRG cells. Mol Pharmacol. 94(1):749–759.
   PubMed Web of Science ®Google Scholar
• Cheung C, Akiyama TE, Kudo G, Gonzalez FJ. 2003. Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice. Biochem Pharmacol. 66(10):2011–2020.
   PubMed Web of Science ®Google Scholar
• Chiang JY. 2009. Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism. Expert Opin Drug Metab Toxicol. 5(2):137–147.
   PubMed Web of Science ®Google Scholar
• Chiang TS, Yang KC, Chiou LL, Huang GT, Lee HS. 2014. Enhancement of CYP3A4 activity in Hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha. PLOS One. 9(4):e94885.
   PubMed Web of Science ®Google Scholar
• Chung I, Bresnick E. 1997. Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch Biochem Biophys. 338(2):220–226.
   PubMed Web of Science ®Google Scholar
• Colleypriest BJ, Burke ZD, Griffiths LP, Chen Y, Yu WY, Jover R, Bock M, Biddlestone L, Quinlan JM, Ward SG, et al. 2017. Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium. Differentiation. 93:39–49.
   PubMed Web of Science ®Google Scholar
• Congiu M, Mashford ML, Slavin JL, Desmond PV. 2009. Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease. J Gastroenterol Hepatol. 24(6):1038–1044.
   PubMed Web of Science ®Google Scholar
• Cubuk H, Yalcin CO. 2021. A review of functional characterization of single amino acid change mutations in HNF transcription factors in MODY pathogenesis. Protein J. 40(3):348–360.
   PubMed Web of Science ®Google Scholar
• Cusato J, De Nicolo A, Boglione L, Favata F, Ariaudo A, Mornese PS, Carcieri C, Guido F, Avataneo V, Cariti G, et al. 2018. Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. J Antimicrob Chemother. 73(6):1659–1664.
   PubMed Web of Science ®Google Scholar
• Cusato J, De Nicolo A, Boglione L, Favata F, Ariaudo A, Mornese PS, Guido F, Avataneo V, Carcieri C, Cariti G, et al. 2017. Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. J Antimicrob Chemother. 72(10):2846–2849.
   PubMed Web of Science ®Google Scholar
• Dai X, Zhang W, Zhang H, Sun S, Yu H, Guo Y, Kou Z, Zhao G, Du L, Jiang S, et al. 2014. Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α. Nucleic Acids Res. 42(10):6578–6590.
   PubMed Web of Science ®Google Scholar
• Del PS, Erkelens DW, Leutenegger M. 2003. Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. Acta Diabetol. 40(1):20–27.
   PubMed Web of Science ®Google Scholar
• Dietrich CG, Martin IV, Porn AC, Voigt S, Gartung C, Trautwein C, Geier A. 2007. Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4alpha and PGC1alpha. Am J Physiol Gastrointest Liver Physiol. 293(3):G585–G590.
   PubMed Web of Science ®Google Scholar
• Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL. 2006. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem. 281(36):26540–26551.
   PubMed Web of Science ®Google Scholar
• Dluzen DF, Lazarus P. 2015. MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors. Drug Metab Rev. 47(3):320–334.
   PubMed Web of Science ®Google Scholar
• Duan Y, Zhu J, Yang J, Gu W, Bai X, Liu G, Xiangyang L. 2021. A decade's review of miRNA: a center of transcriptional regulation of drug-metabolizing enzymes and transporters under hypoxia. Curr Drug Metab. 22(9):709–725.
   PubMed Web of Science ®Google Scholar
• Echchgadda I, Song CS, Oh T, Ahmed M, De La Cruz IJ, Chatterjee B. 2007. The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4α in the regulation of human steroid-/bile acid-sulfotransferase. Mol Endocrinol. 21(9):2099–2111.
   PubMedGoogle Scholar
• Ehmer U, Kalthoff S, Lankisch TO, Freiberg N, Manns MP, Strassburg CP. 2010. Shared regulation of UGT1A7 by hepatocyte nuclear factor (HNF) 1alpha and HNF4alpha. Drug Metab Dispos. 38(7):1246–1257.
   PubMed Web of Science ®Google Scholar
• Florentino RM, Fraunhoffer NA, Morita K, Takeishi K, Ostrowska A, Achreja A, Animasahun O, Haep N, Arazov S, Agarwal N, et al. 2020. Cellular location of HNF4α is linked with terminal liver failure in humans. Hepatol Commun. 4(6):859–875.
   PubMed Web of Science ®Google Scholar
• Forlani G, Zucchini S, Di Rocco A, Di Luzio R, Scipione M, Marasco E, Romeo G, Marchesini G, Mantovani V. 2010. Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report. Diabetes Care. 33(11):2336–2338.
   PubMed Web of Science ®Google Scholar
• Furihata T, Satoh T, Yamamoto N, Kobayashi K, Chiba K. 2007. Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers. Pharm Res. 24(12):2327–2332.
   PubMed Web of Science ®Google Scholar
• Gamou T, Habano W, Terashima J, Ozawa S. 2015. A CAR-responsive enhancer element locating approximately 31 kb upstream in the 5'-flanking region of rat cytochrome P450 (CYP) 3A1 gene. Drug Metab Pharmacokinet. 30(2):188–197.
   PubMed Web of Science ®Google Scholar
• Gao X, Sanderson SM, Dai Z, Reid MA, Cooper DE, Lu M, Richie JJ, Ciccarella A, Calcagnotto A, Mikhael PG, et al. 2019. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature. 572(7769):397–401.
   PubMed Web of Science ®Google Scholar
• Gao Y, Yan Y, Guo J, Zhang Q, Bi D, Wang F, Chang Z, Lu L, Yao X, Wei Q. 2019. HNF-4α downregulation promotes tumor migration and invasion by regulating E-cadherin in renal cell carcinoma. Oncol Rep. 42(3):1066–1074.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen DA, Mackenzie PI. 2007. Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4α. Pharmacogenet Genomics. 17(1):25–36.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen DA, Mackenzie PI. 2007. Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1α. Drug Metab Dispos. 35(1):116–120.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen DA, Mackenzie PI. 2008. Liver-enriched transcription factors and their role in regulating UDP glucuronosyltransferase gene expression. Curr Drug Metab. 9(5):439–452.
   PubMed Web of Science ®Google Scholar
• Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA. 2006. Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology. 130(4):1207–1220.
   PubMed Web of Science ®Google Scholar
• Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, et al. 2005. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol. 289(5):G831–G841.
   PubMed Web of Science ®Google Scholar
• Geier A, Zollner G, Dietrich CG, Wagner M, Fickert P, Denk H, van Rooijen N, Matern S, Gartung C, Trauner M. 2005. Cytokine-independent repression of rodent Ntcp in obstructive cholestasis. Hepatology. 41(3):470–477.
   PubMed Web of Science ®Google Scholar
• Girard R, Darsigny M, Jones C, Maloum-Rami F, Gelinas Y, Carpentier AC, Laplante M, Perreault N, Boudreau F. 2019. HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide. Sci Rep. 9(1):4200.
   PubMedGoogle Scholar
• Godoy P, Schmidt-Heck W, Natarajan K, Lucendo-Villarin B, Szkolnicka D, Asplund A, Bjorquist P, Widera A, Stober R, Campos G, et al. 2015. Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells. J Hepatol. 63(4):934–942.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. 2008. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet. 23(1):2–7.
   PubMed Web of Science ®Google Scholar
• Gregory PA, Hansen AJ, Mackenzie PI. 2000. Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter. Pharmacogenetics. 10(9):809–820.
   PubMedGoogle Scholar
• Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI. 2004. Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1α and the caudal-related homeodomain protein 2. Mol Pharmacol. 65(4):953–963.
   PubMed Web of Science ®Google Scholar
• Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI. 2004. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol. 199(3):354–363.
   PubMed Web of Science ®Google Scholar
• Gregory PA, Mackenzie PI. 2002. The homeodomain Pbx2-Prep1 complex modulates hepatocyte nuclear factor 1alpha-mediated activation of the UDP-glucuronosyltransferase 2B17 gene. Mol Pharmacol. 62(1):154–161.
   PubMed Web of Science ®Google Scholar
• Grimm AA, Brace CS, Wang T, Stormo GD, Imai S. 2011. A nutrient-sensitive interaction between Sirt1 and HNF-1α regulates CRP expression. Aging Cell. 10(2):305–317.
   PubMed Web of Science ®Google Scholar
• Griscelli F, Ezanno H, Soubeyrand M, Feraud O, Oudrhiri N, Bonnefond A, Turhan AG, Froguel P, Bennaceur-Griscelli A. 2018. Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation. Stem Cell Res. 29:56–59.
   PubMed Web of Science ®Google Scholar
• Gu XQ, Tang D, Wan P, Qin T, Yang TH, Wu J, Ji H, Liu JC, Xue F, Tang YJ, et al. 2021. Multiple microRNAs regulate tacrolimus metabolism through CYP3A5. Pharmacol Res. 164:105382.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Kaestner KH. 2004. HNF-4alpha: from MODY to late-onset type 2 diabetes. Trends Mol Med. 10(11):521–524.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Vatamaniuk MZ, Lee CS, Flaschen RC, Fulmer JT, Matschinsky FM, Duncan SA, Kaestner KH. 2005. The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion. J Clin Invest. 115(4):1006–1015.
   PubMed Web of Science ®Google Scholar
• Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. 2001. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 21(4):1393–1403.
   PubMed Web of Science ®Google Scholar
• Hiraiwa H, Pan CJ, Lin B, Akiyama TE, Gonzalez FJ, Chou JY. 2001. A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice. J Biol Chem. 276(11):7963–7967.
   PubMed Web of Science ®Google Scholar
• Holton NW, Singhal M, Kumar A, Ticho AL, Manzella CR, Malhotra P, Jarava D, Saksena S, Dudeja PK, Alrefai WA, et al. 2020. Hepatocyte nuclear factor-4α regulates expression of the serotonin transporter in intestinal epithelial cells. Am J Physiol Cell Physiol. 318(6):C1294–C1304.
   PubMed Web of Science ®Google Scholar
• Hu M, Huang X, Han X, Ji L. 2020. Loss of HNF1α function contributes to hepatocyte proliferation and abnormal cholesterol metabolism via downregulating miR-122: a novel mechanism of MODY3. Diabetes Metab Syndr Obes. 13:627–639.
   PubMed Web of Science ®Google Scholar
• Hu DG, Marri S, Mckinnon RA, Mackenzie PI, Meech R. 2019. Deregulation of the genes that are involved in drug absorption, distribution, metabolism, and excretion in hepatocellular carcinoma. J Pharmacol Exp Ther. 368(3):363–381.
   PubMed Web of Science ®Google Scholar
• Hu DG, Meech R, Mckinnon RA, Mackenzie PI. 2014. Transcriptional regulation of human UDP-glucuronosyltransferase genes. Drug Metab Rev. 46(4):421–458.
   PubMed Web of Science ®Google Scholar
• Huck I, Gunewardena S, Espanol-Suner R, Willenbring H, Apte U. 2019. Hepatocyte nuclear factor 4 alpha activation is essential for termination of liver regeneration in mice. Hepatology. 70(2):666–681.
   PubMed Web of Science ®Google Scholar
• Hwang-Verslues WW, Sladek FM. 2010. HNF4α–role in drug metabolism and potential drug target? Curr Opin Pharmacol. 10(6):698–705.
   PubMed Web of Science ®Google Scholar
• Illés P, Krasulová K, Vyhlídalová B, Poulíková K, Marcalíková A, Pečinková P, Sirotová N, Vrzal R, Mani S, Dvořák Z. 2020. Indole microbial intestinal metabolites expand the repertoire of ligands and agonists of the human pregnane X receptor. Toxicol Lett. 334:87–93.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Hansen AJ, Mackenzie PI. 2000. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol. 57(5):940–947.
   PubMed Web of Science ®Google Scholar
• Jin L, Kikuchi R, Saji T, Kusuhara H, Sugiyama Y. 2012. Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 α/β and DNA methylation. J Pharmacol Exp Ther. 340(3):648–655.
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gomez-Lechon MJ, Castell JV. 2001. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology. 33(3):668–675.
   PubMed Web of Science ®Google Scholar
• Jover R, Moya M, Gomez-Lechon MJ. 2009. Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha. Curr Drug Metab. 10(5):508–519.
   PubMed Web of Science ®Google Scholar
• Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, Kullak-Ublick GA. 2001. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J Biol Chem. 276(40):37206–37214.
   PubMed Web of Science ®Google Scholar
• Juřica J, Dovrtělová G, Nosková K, Zendulka O. 2016. Bile acids, nuclear receptors and cytochrome P450. Physiol Res. 65(Suppl 4):S427–S440.
   PubMedGoogle Scholar
• Kajiwara M, Terada T, Asaka J, Aoki M, Katsura T, Ikai I, Inui K. 2008. Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1). Am J Physiol Gastrointest Liver Physiol. 295(6):G1211–G1216.
   PubMed Web of Science ®Google Scholar
• Kamiya A, Inoue Y, Gonzalez FJ. 2003. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology. 37(6):1375–1384.
   PubMed Web of Science ®Google Scholar
• Kamiyama Y, Matsubara T, Yoshinari K, Nagata K, Kamimura H, Yamazoe Y. 2007. Role of human hepatocyte nuclear factor 4α in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. Drug Metab Pharmacokinet. 22(4):287–298.
   PubMed Web of Science ®Google Scholar
• Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, Minami T, Inoue D, Yoshida K, Yamashita T, et al. 2018. Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma. Hepatol Res. 48(2):205–216.
   PubMed Web of Science ®Google Scholar
• Kleber ME, Grammer TB, Renner W, Marz W. 2010. Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the Ludwigshafen risk and cardiovascular health study). BMC Med Genet. 11:157.
   PubMed Web of Science ®Google Scholar
• Klein K, Winter S, Turpeinen M, Schwab M, Zanger UM. 2010. Pathway-Targeted pharmacogenomics of CYP1A2 in human liver. Front Pharmacol. 1(129):129.
   PubMedGoogle Scholar
• Ko HL, Zhuo Z, Ren EC. 2019. HNF4α combinatorial isoform heterodimers activate distinct gene targets that differ from their corresponding homodimers. Cell Rep. 26(10):2549–2557.
   PubMed Web of Science ®Google Scholar
• Kong D, Xu H, Chen M, Yu Y, Qian Y, Qin T, Tong Y, Xia Q, Hang H. 2020. Co-encapsulation of HNF4α overexpressing UMSCs and human primary hepatocytes ameliorates mouse acute liver failure. Stem Cell Res Ther. 11(1):449.
   PubMed Web of Science ®Google Scholar
• Konstandi M, Cheng J, Gonzalez FJ. 2013. Sex steroid hormones regulate constitutive expression of Cyp2e1 in female mouse liver. Am J Physiol Endocrinol Metab. 304(10):E1118–E1128.
   PubMed Web of Science ®Google Scholar
• Lamba V, Ghodke Y, Guan W, Tracy TS. 2014. MicroRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450. Biochem Biophys Res Commun. 445(2):404–411.
   PubMed Web of Science ®Google Scholar
• Lambert É, Babeu J-P, Simoneau J, Raisch J, Lavergne L, Lévesque D, Jolibois É, Avino M, Scott MS, Boudreau F, et al. 2020. Human hepatocyte nuclear factor 4-α encodes isoforms with distinct transcriptional functions. Mol Cell Proteomics. 19(5):808–827.,.
   PubMed Web of Science ®Google Scholar
• Lau HH, Ng N, Loo L, Jasmen JB, Teo A. 2018. The molecular functions of hepatocyte nuclear factors – in and beyond the liver. J Hepatol. 68(5):1033–1048.
   PubMed Web of Science ®Google Scholar
• Lazarevich NL, Shavochkina DA, Fleishman DI, Kustova IF, Morozova OV, Chuchuev ES, Patyutko YI. 2010. Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression. Exp Oncol. 32(3):167–171.
   PubMedGoogle Scholar
• Lee SH, Athavankar S, Cohen T, Piran R, Kiselyuk A, Levine F. 2013. Identification of alverine and benfluorex as HNF4α activators. ACS Chem Biol. 8(8):1730–1736.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen H. 2019. MiR-34a inhibits proliferation, migration and invasion of paediatric neuroblastoma cells via targeting HNF4α. Artif Cells Nanomed Biotechnol. 47(1):3072–3078.
   PubMed Web of Science ®Google Scholar
• Li Y, Hao B, Muhammad I, Zhang Y, Yang Y, Shi C, Chang Y, Li R, Li C, Liu F. 2019. Acetaminophen-induced reduction in glutathione-S-transferase A1 in hepatocytes: a role for hepatic nuclear factor 1alpha and its response element. Biochem Biophys Res Commun. 516(1):251–257.
   PubMed Web of Science ®Google Scholar
• Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, et al. 2019. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B. 9(6):1113–1144.
   PubMed Web of Science ®Google Scholar
• Lim KT, Kim J, Hwang SI, Zhang L, Han H, Bae D, Kim KP, Hu YP, Scholer HR, Lee I, et al. 2018. Direct conversion of mouse fibroblasts into cholangiocyte progenitor cells. Stem Cell Reports. 10(5):1522–1536.
   PubMed Web of Science ®Google Scholar
• Lin J, Gu C, Shen Z, Liu Y, Wang W, Tao S, Cui X, Liu J, Xie Y. 2017. Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway. PLoS One. 12(3):e174017.
   PubMed Web of Science ®Google Scholar
• Liu SY, Gonzalez FJ. 1995. Role of the liver-enriched transcription factor HNF-1α in expression of the CYP2E1 gene. DNA Cell Biol. 14(4):285–293.
   PubMed Web of Science ®Google Scholar
• Lu H. 2016. Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids. Acta Pharm Sin B. 6(5):393–408.
   PubMed Web of Science ®Google Scholar
• Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, Ryffel GU. 2005. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene. 24(42):6418–6431.
   PubMed Web of Science ®Google Scholar
• Lv DD, Zhou LY, Tang H. 2021. Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment. Exp Mol Med. 53(1):8–18.
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Hu DG, Gardner-Stephen DA. 2010. The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors. Drug Metab Rev. 42(1):99–109.
   PubMed Web of Science ®Google Scholar
• Maestro MA, Cardalda C, Boj SF, Luco RF, Servitja JM, Ferrer J. 2007. Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth. Endocr Dev. 12:33–45.
   PubMedGoogle Scholar
• Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheung C, Gonzalez FJ, Klaassen CD. 2006. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol. 72(4):512–522.
   PubMed Web of Science ®Google Scholar
• Martinez-Jimenez CP, Castell JV, Gomez-Lechon MJ, Jover R. 2006. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4α requires coactivators peroxisomal proliferator activated receptor-γ coactivator 1α and steroid receptor coactivator 1. Mol Pharmacol. 70(5):1681–1692.
   PubMed Web of Science ®Google Scholar
• Matsumura K, Saito T, Takahashi Y, Ozeki T, Kiyotani K, Fujieda M, Yamazaki H, Kunitoh H, Kamataki T. 2004. Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol. 65(2):326–334.
   PubMed Web of Science ®Google Scholar
• Meijer I, Willems S, Ni X, Heering J, Chaikuad A, Merk D. 2020. Chemical starting matter for HNF4α ligand discovery and chemogenomics. IJMS. 21(21):7895.
   Google Scholar
• Moulin P, Andre M, Alawi H, Dos SL, Khalid AK, Koev D, Moore R, Serban V, Picandet B, Francillard M. 2006. Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind study. Diabetes Care. 29(3):515–520.
   PubMed Web of Science ®Google Scholar
• Mounajjed T, Yasir S, Aleff PA, Torbenson MS. 2015. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Mod Pathol. 28(9):1265–1274.
   PubMed Web of Science ®Google Scholar
• Mubarokah N, Hulin JA, Mackenzie PI, Mckinnon RA, Haines AZ, Hu DG, Meech R. 2018. Cooperative regulation of intestinal UDP-glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α is mediated by a novel composite regulatory element. Mol Pharmacol. 93(5):541–552.
   PubMed Web of Science ®Google Scholar
• Ni Q, Ding K, Wang KQ, He J, Yin C, Shi J, Zhang X, Xie WF, Shi YQ. 2017. Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice. FEBS Lett. 591(13):1947–1957.
   PubMed Web of Science ®Google Scholar
• Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, et al. 2010. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res. 70(19):7640–7651.
   PubMed Web of Science ®Google Scholar
• Nozaki K, Nakano M, Iwakami C, Fukami T, Nakajima M. 2019. RNA editing enzymes modulate the expression of hepatic CYP2B6, CYP2C8, and other cytochrome p450 isoforms. Drug Metab Dispos. 47(6):639–647.
   PubMed Web of Science ®Google Scholar
• Nuclear Receptors Nomenclature Committee. 1999. A unified nomenclature system for the nuclear receptor superfamily. Cell. 97(2):161–163.
   PubMed Web of Science ®Google Scholar
• Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al. 2004. Control of pancreas and liver gene expression by HNF transcription factors. Science. 303(5662):1378–1381.
   PubMed Web of Science ®Google Scholar
• Ondo K, Isono M, Nakano M, Hashiba S, Fukami T, Nakajima M. 2021. The N6-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression. Biochem Pharmacol. 189:114402.
   PubMed Web of Science ®Google Scholar
• Park SH, Waxman DJ. 2001. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: Impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J Biol Chem. 276(46):43031–43039.
   PubMed Web of Science ®Google Scholar
• Patitucci C, Couchy G, Bagattin A, Caneque T, de Reynies A, Scoazec JY, Rodriguez R, Pontoglio M, Zucman-Rossi J, Pende M, et al. 2017. Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription. J Clin Invest. 127(5):1873–1888.
   PubMed Web of Science ®Google Scholar
• Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, Ellard S, Ferrer J, Hattersley AT. 2007. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 4(4):e118.
   PubMed Web of Science ®Google Scholar
• Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. 2003. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 362(9392):1275–1281.
   PubMed Web of Science ®Google Scholar
• Piessen G, Jonckheere N, Vincent A, Hemon B, Ducourouble MP, Copin MC, Mariette C, Van Seuningen I. 2007. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha. Biochem J. 402(1):81–91.
   PubMedGoogle Scholar
• Prajapati KD, Sharma SS, Roy N. 2012. Hepatocyte nuclear factor-1alpha mediated upregulation of albumin expression in focal ischemic rat brain. Neurol Res. 34(1):25–31.
   PubMed Web of Science ®Google Scholar
• Prie D. 2014. Familial renal glycosuria and modifications of glucose renal excretion. Diabetes Metab. 40(6 Suppl 1):S12–S16.
   PubMedGoogle Scholar
• Qadri I, Hu LJ, Iwahashi M, Al-Zuabi S, Quattrochi LC, Simon FR. 2009. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2). Toxicol Appl Pharmacol. 234(3):281–292.
   PubMed Web of Science ®Google Scholar
• Qadri I, Iwahashi M, Kullak-Ublick GA, Simon FR. 2006. Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 up-regulation during hepatitis C virus gene expression. Mol Pharmacol. 70(2):627–636.
   PubMed Web of Science ®Google Scholar
• Qian H, Deng X, Huang ZW, Wei J, Ding CH, Feng RX, Zeng X, Chen YX, Ding J, Qiu L, et al. 2015. An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Res. 25(8):930–945.
   PubMed Web of Science ®Google Scholar
• Ramirez J, Mirkov S, Zhang W, Chen P, Das S, Liu W, Ratain MJ, Innocenti F. 2008. Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver. Pharmacogenomics J. 8(2):152–161.
   PubMed Web of Science ®Google Scholar
• Rana R, Chen Y, Ferguson SS, Kissling GE, Surapureddi S, Goldstein JA. 2010. Hepatocyte nuclear factor 4{alpha} regulates rifampicin-mediated induction of CYP2C genes in primary cultures of human hepatocytes. Drug Metab Dispos. 38(4):591–599.
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. 2008. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 48(1):163–170.
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Vasiliu V, Thomas C, Bellanne-Chantelot C, Bui H, Chretien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, et al. 2005. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet. 14(5):603–614.
   PubMed Web of Science ®Google Scholar
• Rosenthal SB, Bush KT, Nigam SK. 2019. A network of SLC and ABC transporter and DME genes involved in remote sensing and signaling in the gut-liver-kidney axis. Sci Rep. 9(1):11879.
   PubMedGoogle Scholar
• Rosner GL, Panetta JC, Innocenti F, Ratain MJ. 2008. Pharmacogenetic pathway analysis of irinotecan. Clin Pharmacol Ther. 84(3):393–402.
   PubMed Web of Science ®Google Scholar
• Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, et al. 2014. Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer. Nature. 513(7516):110–114.
   PubMed Web of Science ®Google Scholar
• Sato Y, Rahman MM, Haneda M, Tsuyama T, Mizumoto T, Yoshizawa T, Kitamura T, Gonzalez FJ, Yamamura K, Yamagata K. 2020. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1. Biochim Biophys Acta Mol Basis Dis. 1866(11):165898.
   PubMed Web of Science ®Google Scholar
• Servitja JM, Pignatelli M, Maestro MA, Cardalda C, Boj SF, Lozano J, Blanco E, Lafuente A, Mccarthy MI, Sumoy L, et al. 2009. Hnf1α (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver. Mol Cell Biol. 29(11):2945–2959.
   PubMed Web of Science ®Google Scholar
• Shen CH, Zhang YX, Lu RY, Jin B, Wang S, Liu ZR, Tang YL, Ding MP. 2016. Specific OCT1 and ABCG2 polymorphisms are associated with lamotrigine concentrations in Chinese patients with epilepsy. Epilepsy Res. 127:186–190.
   PubMed Web of Science ®Google Scholar
• Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, et al. 2001. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet. 27(4):375–382.
   PubMed Web of Science ®Google Scholar
• Skowronek R, Czekaj P, Suszka-Świtek A, Czech E, Wiaderkiewicz A, Plewka D, Bryzek A. 2016. Expression of cytochrome P450 2C and 3A in female rat liver after long-term administration of gonadoliberin analogs. Int J Occup Med Environ Health. 29(2):293–314.
   PubMed Web of Science ®Google Scholar
• Spaninger E, Potocnik U, Bren U. 2020. Molecular dynamics simulations predict that rSNP located in the HNF1α gene promotor region linked with MODY3 and hepatocellular carcinoma promotes stronger binding of the HNF4α transcription factor. Biomolecules. 10(12):1700.
   PubMed Web of Science ®Google Scholar
• Stoffel M, Duncan SA. 1997. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA. 94(24):13209–13214.
   PubMed Web of Science ®Google Scholar
• Subramani R, Medel J, Flores K, Perry C, Galvez A, Sandoval M, Rivera S, Pedroza DA, Penner E, Chitti M, et al. 2020. Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasis. Sci Rep. 10(1):20225.
   PubMed Web of Science ®Google Scholar
• Sucajtys-Szulc E, Debska-Slizien A, Rutkowski B, Milczarek R, Pelikant-Malecka I, Sledzinski T, Swierczynski J, Szolkiewicz M. 2018. Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure. Mol Cell Biochem. 446(1–2):11–23.
   PubMed Web of Science ®Google Scholar
• Sugai M, Umezu H, Yamamoto T, Jiang S, Iwanari H, Tanaka T, Hamakubo T, Kodama T, Naito M. 2008. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors. Pathol Int. 58(11):681–686.
   PubMed Web of Science ®Google Scholar
• Sugano M, Nagasaka T, Sasaki E, Murakami Y, Hosoda W, Hida T, Mitsudomi T, Yatabe Y. 2013. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung. Am J Surg Pathol. 37(2):211–218.
   PubMed Web of Science ®Google Scholar
• Sugatani J, Wada T, Osabe M, Yamakawa K, Yoshinari K, Miwa M. 2006. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression. Drug Metab Dispos. 34(10):1677–1687.
   PubMed Web of Science ®Google Scholar
• Sugawara M, Okamoto K, Kadowaki T, Kusano K, Fukamizu A, Yoshimura T. 2010. Expressions of cytochrome P450, UDP-glucuronosyltranferase, and transporter genes in monolayer carcinoma cells change in subcutaneous tumors grown as xenografts in immunodeficient nude mice. Drug Metab Dispos. 38(3):526–533.
   PubMed Web of Science ®Google Scholar
• Sun Q, Xu W, Ji S, Qin Y, Liu W, Hu Q, Zhang Z, Liu M, Yu X, Xu X. 2019. Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma. Cancer Cell Int. 19:49.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131(5):861–872.
   PubMed Web of Science ®Google Scholar
• Tan J, Xu J, Wei G, Zhang L, Sun L, Wang G, Li F, Jiang F. 2019. HNF1α controls liver lipid metabolism and insulin resistance via negatively regulating the SOCS-3-STAT3 signaling pathway. J Diabetes Res. 2019:5483946.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Chen C, Maher JM, Klaassen CD. 2006. Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion. Transplantation. 82(2):258–266.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K, Daigo K, Ohashi R, Sugai M, Ikegame C, et al. 2006. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol. 208(5):662–672.
   PubMed Web of Science ®Google Scholar
• Taneja G, Maity S, Jiang W, Moorthy B, Coarfa C, Ghose R. 2019. Transcriptomic profiling identifies novel mechanisms of transcriptional regulation of the cytochrome P450 (Cyp)3a11 gene. Sci Rep. 9(1):6663.
   PubMedGoogle Scholar
• Tavares-Sanchez OL, Rodriguez C, Gortares-Moroyoqui P, Estrada MI. 2015. Hepatocyte nuclear factor-4α, a multifunctional nuclear receptor associated with cardiovascular disease and cholesterol catabolism. Int J Environ Health Res. 25(2):126–139.
   PubMed Web of Science ®Google Scholar
• Teeli AS, Łuczyńska K, Haque E, Gayas MA, Winiarczyk D, Taniguchi H. 2021. Disruption of tumor suppressors HNF4α/HNF1α causes tumorigenesis in liver. Cancers. 13(21):5357.
   PubMed Web of Science ®Google Scholar
• Terryn S, Tanaka K, Lengele JP, Olinger E, Dubois-Laforgue D, Garbay S, Kozyraki R, Van Der Smissen P, Christensen EI, Courtoy PJ, et al. 2016. Tubular proteinuria in patients with HNF1α mutations: HNF1α drives endocytosis in the proximal tubule. Kidney Int. 89(5):1075–1089.
   PubMed Web of Science ®Google Scholar
• Thangavel C, Boopathi E, Shapiro BH. 2013. Inherent sex-dependent regulation of human hepatic CYP3A5. Br J Pharmacol. 168(4):988–1000.
   PubMed Web of Science ®Google Scholar
• Thomas C, Landrier JF, Gaillard D, Grober J, Monnot MC, Athias A, Besnard P. 2006. Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences. Gut. 55(9):1321–1331.
   PubMed Web of Science ®Google Scholar
• Tirona RG, Kim RB. 2005. Nuclear receptors and drug disposition gene regulation. J Pharm Sci. 94(6):1169–1186.
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, et al. 2003. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med. 9(2):220–224.
   PubMed Web of Science ®Google Scholar
• Torres-Padilla ME, Fougere-Deschatrette C, Weiss MC. 2001. Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing. Mech Dev. 109(2):183–193.
   PubMed Web of Science ®Google Scholar
• Uno Y, Sakamoto Y, Yoshida K, Hasegawa T, Hasegawa Y, Koshino T, Inoue I. 2003. Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter. J Hum Genet. 48(11):594–597.
   PubMed Web of Science ®Google Scholar
• van der Post RS, Bult P, Vogelaar IP, Ligtenberg MJ, Hoogerbrugge N, van Krieken JH. 2014. HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch. 464(6):673–679.
   PubMed Web of Science ®Google Scholar
• Velenosi TJ, Feere DA, Sohi G, Hardy DB, Urquhart BL. 2014. Decreased nuclear receptor activity and epigenetic modulation associates with down-regulation of hepatic drug-metabolizing enzymes in chronic kidney disease. FASEB J. 28(12):5388–5397.
   PubMed Web of Science ®Google Scholar
• Vuong LM, Chellappa K, Dhahbi JM, Deans JR, Fang B, Bolotin E, Titova NV, Hoverter NP, Spindler SR, Waterman ML, et al. 2015. Differential effects of hepatocyte nuclear factor 4α isoforms on tumor growth and T-Cell factor 4/AP-1 interactions in human colorectal cancer cells. Mol Cell Biol. 35(20):3471–3490.
   PubMed Web of Science ®Google Scholar
• Walesky C, Apte U. 2015. Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer. Gene Expr. 16(3):101–108.
   PubMed Web of Science ®Google Scholar
• Wang P, Chen S, Wang Y, Wang X, Yan L, Yang K, Zhong XB, Han S, Zhang L. 2021. The long noncoding RNA hepatocyte nuclear factor 4α antisense RNA 1 negatively regulates cytochrome P450 enzymes in Huh7 cells via histone modifications. Drug Metab Dispos. 49(5):361–368.
   PubMed Web of Science ®Google Scholar
• Wang X, Hassan W, Zhao J, Bakht S, Nie Y, Wang Y, Pang Q, Huang Z. 2019. The impact of hepatocyte nuclear factor-1α on liver malignancies and cell stemness with metabolic consequences. Stem Cell Res Ther. 10(1):315.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Wu D, Yu S, Wang Y, Leung CF. 2020. Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence. Oncogene. 39(7):1572–1589.
   PubMed Web of Science ®Google Scholar
• Wang AW, Wang YJ, Zahm AM, Morgan AR, Wangensteen KJ, Kaestner KH. 2020. The dynamic chromatin architecture of the regenerating liver. Cell Mol Gastroenterol Hepatol. 9(1):121–143.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yan L, Liu J, Chen S, Liu G, Nie Y, Wang P, Yang W, Chen L, Zhong X, et al. 2019. The HNF1α-regulated lncRNA HNF1α-AS1 is involved in the regulation of cytochrome p450 expression in human liver tissues and huh7 cells. J Pharmacol Exp Ther. 368(3):353–362.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Y, Zhang J, Deng Q, Liang H. 2021. Controversial roles of hepatocyte nuclear receptor 4α on tumorigenesis. Oncol Lett. 21(5):356.
   PubMed Web of Science ®Google Scholar
• Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, et al. 2004. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos. 32(3):281–290.
   PubMed Web of Science ®Google Scholar
• Wiwi CA, Waxman DJ. 2004. Role of hepatocyte nuclear factors in growth hormone-regulated, sexually dimorphic expression of liver cytochromes P450. Growth Factors. 22(2):79–88.
   PubMed Web of Science ®Google Scholar
• Wortham M, Czerwinski M, He L, Parkinson A, Wan YJ. 2007. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos. 35(9):1700–1710.
   PubMed Web of Science ®Google Scholar
• Wu M, Dong B, Cao A, Li H, Liu J. 2012. Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters. Atherosclerosis. 224(2):401–410.
   PubMed Web of Science ®Google Scholar
• Xie HG, Lee W, Yu C, Stein CM, Kim RB. 2005. Hepatocyte nuclear factors (HNF) 4α and 1α synergistically up-regulate car-mediated transcriptional activity of human CYP2C9 gene. Clin Pharmacol Ther. 77(2):P23–P23.
   Web of Science ®Google Scholar
• Xu J, Filetti S, Hershman JM. 2008. Expression of hepatocyte nuclear factor-1alpha mRNA in human anaplastic thyroid cancer cell lines and tumors. Thyroid. 18(5):533–539.
   PubMed Web of Science ®Google Scholar
• Xu Q, Li Y, Gao X, Kang K, Williams JG, Tong L, Liu J, Ji M, Deterding LJ, Tong X, et al. 2020. HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer. Nat Commun. 11(1):3978.
   PubMed Web of Science ®Google Scholar
• Xu C, Ooi WF, Qamra A, Tan J, Chua BY, Ho SWT, Das K, Adam Isa ZF, Li Z, Yao X, et al. 2020. HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer. Gut. 69(2):231–242.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhu Y, Hu S, Xu Y, Stroup D, Pan X, Bawa FC, Chen S, Gopoju R, Yin L, et al. 2021. Hepatocyte nuclear factor 4α prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice). Hepatology. 73(6):2251–2265.
   PubMed Web of Science ®Google Scholar
• Yamagata K. 2014. Roles of HNF1alpha and HNF4alpha in pancreatic beta-cells: lessons from a monogenic form of diabetes (MODY). Vitam Horm. 95:407–423.
   PubMed Web of Science ®Google Scholar
• Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. 1996. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 384(6608):458–460.
   PubMed Web of Science ®Google Scholar
• Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, et al. 1996. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 384(6608):455–458.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang M, Zhao Y, Pan Y, Kan M, Li J, He K, Zhang X. 2020. HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway. PLoS One. 15(3):e230450.
   Web of Science ®Google Scholar
• Yeh MM, Bosch DE, Daoud SS. 2019. Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases. World J Gastroenterol. 25(30):4074–4091.
   PubMed Web of Science ®Google Scholar
• Yuan X, Lu H, Zhao A, Ding Y, Min Q, Wang R. 2020. Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia. Drug Metab Rev. 52(2):225–234.
   PubMed Web of Science ®Google Scholar
• Yue HY, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, Hu PF, Deng X, Tan YX, Zhang JP, et al. 2010. Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats. Gut. 59(2):236–246.
   PubMed Web of Science ®Google Scholar
• Yueh MF, Mellon PL, Tukey RH. 2011. Inhibition of human UGT2B7 gene expression in transgenic mice by the constitutive androstane receptor. Mol Pharmacol. 79(6):1053–1060.
   PubMed Web of Science ®Google Scholar
• Zeng X, Lin Y, Yin C, Zhang X, Ning BF, Zhang Q, Zhang JP, Qiu L, Qin XR, Chen YX, et al. 2011. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology. 54(6):2036–2047.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li R, Rong W, Han M, Cui C, Feng Z, Sun X, Jin S. 2018. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis. Cell Death Dis. 9(12):1186.
   PubMedGoogle Scholar
• Zhang L, Xu P, Cheng Y, Wang P, Ma X, Liu M, Wang X, Xu F. 2019. Diet-induced obese alters the expression and function of hepatic drug-metabolizing enzymes and transporters in rats. Biochem Pharmacol. 164:368–376.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang X, Li H, Zhang J, Chen Z, Xie W, Zhang J, Li J, Zhou L, Huang M. 2015. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients. Drug Metab Pharmacokinet. 30(4):282–287.
   PubMed Web of Science ®Google Scholar
• Zhou YJ, Yin RX, Hong SC, Yang Q, Cao XL, Chen WX. 2017. Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke. J Gene Med. 19(1–2):e2941.
   PubMed Web of Science ®Google Scholar